Persistent neurotoxicity interferon-alpha Fourteen cancer patients evidence persistent neurotoxicity interferon-alpha therapy treatment cognitive symptoms mild severity individuals usual work neuropsychological test abnormalities attributable subsequent therapy disease status medical problems pattern deficits consistent frontal-subcortical dysfunction patients follow-up assessment findings cases neurotoxicity reversible 